Iambic Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 13.43 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 636.59M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally. It offers products, such as IAM-1363, a selective HER2 inhibitor; IAM-K1, a KIF18A inhibitor; IAM217 (a KIF18A inhibitor) and IAM-C1, a CDK2/4 inhibitor; and services, including drug discovery platform and molecular superintelligence platform which includes technologies, such as Enchant and NeuralPLexer to design and develop sm...